Article Versions Notes

Levin MJ, Rawashdh NA, Mofor L, Anaya P, Zur RM, Kahn EB, Yu D, Mould-Quevedo JF. A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States. Vaccines. 2024; 12(11):1217. https://doi.org/10.3390/vaccines12111217

Levin, Myron J., Neda Al Rawashdh, Liliane Mofor, Pablo Anaya, Richard M. Zur, Emily B. Kahn, Daniel Yu, and Joaquin F. Mould-Quevedo. 2024. "A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States" Vaccines 12, no. 11: 1217. https://doi.org/10.3390/vaccines12111217

Levin, M. J., Rawashdh, N. A., Mofor, L., Anaya, P., Zur, R. M., Kahn, E. B., Yu, D., & Mould-Quevedo, J. F. (2024). A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States. Vaccines, 12(11), 1217. https://doi.org/10.3390/vaccines12111217